Australia Bariatric Surgery Market Size

Australia Bariatric Surgery Market Analysis

The Australian bariatric surgery market is anticipated to grow at a CAGR of 5.6% during the forecast period.

COVID-19 had a significant impact on market growth due to the postponement of elective surgeries during the pandemic. This reduced the total number of surgeries performed across Australia and adversely impacted the bariatric surgery market. However, the new guidelines made for the continuation of these surgeries helped healthcare practitioners to perform various procedures and are expected to have a positive impact on the market. For instance, as per the report published by Aspiring Bariatrics in March 2022, the guidelines from the Australian and New Zealand College of Anaesthetists recommend that planned minor surgery is delayed for at least 4 weeks after a Covid-19 infection and major surgery is delayed for at least 7 weeks after a Covid-19 infection. This will ensure patient safety and can establish a better outcome which is expected to drive the market over the coming future.

The major factors contributing to the growth of the bariatric surgery market include an increase in obesity among people, the rising burden of diabetes and heart diseases, and rapid technological advancements and innovations in devices.

In Australia, being overweight or obese is a serious public health concern and a substantial risk factor for illness. For instance, according to the Australian Institute of Health and Welfare (AIHW) data updated in July 2022, 2 in 3 (67%) Australians aged 18 and over were overweight or obese (36% were overweight but not obese, and 31% were obese). That is around 12.5 million adults. Men had higher rates of overweight and obesity than women (75% of men and 60% of women) and higher rates of obesity (33% of men and 30% of women). Hence, with the high prevalence of obesity, the demand for bariatric surgeries increases, which is expected to propel market growth.

Moreover, the rising prevalence of cardiovascular diseases is expected to drive the market's growth in the forecast period as it increases the demand for bariatric surgery to prevent CVD-related morbidities. For instance, according to the AIHW, 2022, in the year 2020-2021, an estimated 571,000 Australians aged 18 and over (2.9% of the adult population) had chronic heart diseases. Thus, due to the rising prevalence of chronic illnesses like diabetes and cardiovascular disease (CVD) in the population, there is an increasing need for bariatric surgery to reduce the morbidities associated with CVD, which is expected to drive the market to grow. However, the high cost of surgery may restrain the market's growth.